Form 4: Personalis Director A. Blaine Bowman Granted Stock Options

Director A. Blaine Bowman of Personalis, Inc. was granted stock options to purchase 50,000 shares of common stock at an exercise price of $4.95 on May 16, 2025.

Summary

• A Form 4 filing reveals that A. Blaine Bowman, a director of Personalis, Inc., was granted stock options on May 16, 2025.
• The options allow Bowman to purchase 50,000 shares of Personalis common stock at an exercise price of $4.95 per share.
• The options vest on the earlier of the one-year anniversary of the grant date or the day prior to the company's next annual meeting of stockholders after the grant date, contingent upon Bowman's continuous service.
• In the event of a change in control, the options will vest immediately prior to the change in control becoming effective.
• The options expire on May 16, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and suggests confidence in the company's future performance. It aligns the director's interests with those of the shareholders.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.
• The change in control provision ensures the director is rewarded even if the company is acquired.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation. This grant is typical for directors of publicly traded companies.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• Companies like Illumina, Inc. and Thermo Fisher Scientific also utilize stock options as part of their director compensation plans.
• The vesting schedule and exercise price are generally aligned with industry norms to incentivize long-term value creation.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a sign of the company's commitment to incentivizing its leadership.

Key Dates

Keywords

stock options, Form 4, Personalis, director, Bowman, equity, vesting